Zydus Lifesciences Gains After USFDA Clears Ahmedabad Facility
Mumbai, September 22 (Udaipur Kiran News): Shares of Zydus Lifesciences Ltd edged higher on the BSE after the company received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its oncology injectable facility in Ahmedabad. The stock was trading at ₹1,040.65, up ₹3.65 or 0.35% from the previous close of … Read more
